NEK4 and cancer: Interestingly, recent studies also point toward NEK4 involvement in critical processes that drive cancer progression, such as the epithelial–mesenchymal transition (EMT), mitochondrial dynamics, and the sensitivity of cancer cells to chemotherapy [127].